Outstanding Resident Award recipient and former Scripps Mercy Hospital Internal Medicine Chief Resident Dr. G. Weldon Gilcrease III earned his MD from the University of Arizona College of Medicine before completing his internal medicine residency at the Fifth Avenue Scripps Mercy campus. The program's Chief Resident position and Outstanding Resident Award for teaching and patient care came during those training years at 4077 Fifth Avenue, the same campus that houses the Scripps Mercy San Diego Emergency Room where internal-medicine residents rotated on admissions. Since 2009 his clinical practice has been based at Huntsman Cancer Institute and the University of Utah School of Medicine, where he directs the Hematology/Oncology Fellowship program and runs early-phase gastrointestinal-cancer trials focused on colorectal drug development and beta-catenin pathway targeting. His research portfolio includes Phase I/II trials for inoperable colorectal cancer and recent publications on liver-directed therapy outcomes for localized hepatocellular carcinoma. Active hematology/oncology care at this Hillcrest campus now runs through Scripps-affiliated oncologists including Marin Xavier, MD, who practices within the Scripps Clinic Mercy – Prebys Cancer Center on the same medical block. The most complex cases Dr. Gilcrease now handles at Huntsman involve enrolling metastatic colorectal-cancer patients into biomarker-selected targeted-therapy trials after first- and second-line chemotherapy has failed.